<DOC>
	<DOCNO>NCT00140894</DOCNO>
	<brief_summary>A study evaluate rofecoxib treatment rectal , colon , duodenal adenoma patient Familial Adenomatous Polyposis .</brief_summary>
	<brief_title>A Study Rofecoxib Familial Adenomatous Polyposis ( FAP )</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Adenomatous Polyposis Coli</mesh_term>
	<mesh_term>Rofecoxib</mesh_term>
	<criteria>Males female least 18 year age familial adenomatous polyposis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2006</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Cancer Pain</keyword>
</DOC>